News|Articles|March 13, 2024
Overcoming oncolytic virus therapy production challenges through collaboration
Author(s)ReciBioPharm
Discover how ReciBioPharm’s strategic approach helped to support the rapid delivery of an innovative oncolytic adenovirus therapy for advanced cancer to clinic.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
FAQ: What You Need to Know About Modern Vaccine Development and Compliance
2
CDC’s Policy Shift on Autism and Vaccines Spurs Biopharma Quality/System Concerns
3
BioPharm Weekly News Roundup—Week of Nov. 17, 2025
4
How Sapient’s Next-Gen Proteomics Platform Helps Quantify Proteins at Scale
5
